The ZMYM4-OPRD1 fusion gene has been associated with breast cancer [108], while ZMYM4 has been associated with colonic and gastric cancers, malignant melanoma, hepatocellular carcinoma and pancreatic carcinomas. This evidence concerns the gene OPRD1 and hepatocellular carcinoma.